关于《马里兰州避孕公平法案》的探索性调查：临床医生的认知及其对避孕服务提供的影响
An exploratory survey regarding the Maryland Contraceptive Equity Act: clinician awareness and impact on contraception provision.
作者信息
Cheedalla Aneesha, Lee Jessica K, Burke Anne E
机构信息
Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Department of Obstetrics and Gynecology, University of Maryland Medical System, Baltimore, MD, United States of America.
出版信息
Contracept X. 2022 Jan 2;4:100071. doi: 10.1016/j.conx.2021.100071. eCollection 2022.
OBJECTIVE
The Maryland Contraceptive Equity Act took effect in January 2018 with the goal of reducing insurance barriers to contraception. We sought to assess the Act's impact on contraceptive provision.
STUDY DESIGN
From March-August 2019, we emailed an exploratory survey to clinicians providing contraception in Maryland that queried awareness of the Act and changing practices.
RESULTS
The survey had a 13% response rate (164/1256 clinicians). Fifty (31%) were aware of the Act. Clinicians rated the Act was somewhat likely to change prescribing practices (3.5/5 point Likert Scale, SD 1.3).
CONCLUSION
The majority of clinicians providing contraception in Maryland are not aware of the Act. If aware of the Act, clinicians may change their contraceptive prescribing practices.
目的
《马里兰州避孕公平法案》于2018年1月生效，目标是减少避孕的保险障碍。我们试图评估该法案对避孕服务提供的影响。
研究设计
2019年3月至8月，我们向在马里兰州提供避孕服务的临床医生发送了一项探索性调查，询问他们对该法案的了解情况以及做法的变化。
结果
调查回复率为13%（164/1256名临床医生）。50人（31%）知晓该法案。临床医生认为该法案在某种程度上可能会改变处方习惯（李克特量表评分为3.5/5分，标准差为1.3）。
结论
在马里兰州提供避孕服务的大多数临床医生并不知晓该法案。如果知晓该法案，临床医生可能会改变他们的避孕处方习惯。
Zotero 插件